Karlien Pieters
Overview
Explore the profile of Karlien Pieters including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
419
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Draguet F, Dubois N, Bouland C, Pieters K, Bron D, Meuleman N, et al.
Cancers (Basel)
. 2023 Jun;
15(11).
PMID: 37296864
Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal cancers worldwide. Treatment of PDAC remains a major challenge. This study aims to evaluate, in vitro, the use of human...
2.
Stamatopoulos B, Smith T, Crompot E, Pieters K, Clifford R, Mraz M, et al.
Clin Cancer Res
. 2018 Jun;
24(20):5048-5057.
PMID: 29945996
Unmutated (UM) immunoglobulin heavy chain variable region (IgHV) status or IgHV3-21 gene usage is associated with poor prognosis in chronic lymphocytic leukemia (CLL) patients. Interestingly, IgHV3-21 is often co-expressed with...
3.
Crompot E, Van Damme M, Pieters K, Vermeersch M, Perez-Morga D, Mineur P, et al.
Haematologica
. 2017 Jun;
102(9):1594-1604.
PMID: 28596280
Interactions between chronic lymphocytic leukemia (CLL) B cells and the bone marrow (BM) microenvironment play a major function in the physiopathology of CLL. Extracellular vesicles (EVs), which are composed of...
4.
Najar M, Raicevic G, Andre T, Fayyad-Kazan H, Pieters K, Bron D, et al.
Cytotherapy
. 2016 Feb;
18(3):320-35.
PMID: 26857227
Background Aims: Because of their self-renewal capacity, multilineage potential and immunomodulatory properties, MSCs are an attractive tool for cell-based immunotherapy strategies. Foreskin, considered as a biological waste material, has been...
5.
de la Kethulle de Ryhove L, Ansseau E, Nachtegael C, Pieters K, Vanderplanck C, Geens M, et al.
Stem Cells Dev
. 2015 Jul;
24(22):2674-86.
PMID: 26192274
Facioscapulohumeral muscular dystrophy (FSHD) is associated with an activation of the double homeobox 4 (DUX4) gene, which we previously identified within the D4Z4 repeated elements in the 4q35 subtelomeric region....
6.
Busser H, Najar M, Raicevic G, Pieters K, Velez Pombo R, Philippart P, et al.
Stem Cells Dev
. 2015 Jun;
24(18):2142-57.
PMID: 26086188
Preparations of mesenchymal stromal cells (MSCs) are generally obtained from unfractionated tissue cells, resulting in heterogeneous cell mixtures. Several markers were proposed to enrich these cells, but the majority of...
7.
Crompot E, Van Damme M, Duvillier H, Pieters K, Vermeesch M, Perez-Morga D, et al.
PLoS One
. 2015 May;
10(5):e0127209.
PMID: 25978814
Background: Microparticles (MPs), also called microvesicles (MVs) are plasma membrane-derived fragments with sizes ranging from 0.1 to 1μm. Characterization of these MPs is often performed by flow cytometry but there...
8.
Andre T, Najar M, Stamatopoulos B, Pieters K, Pradier O, Bron D, et al.
Cancer Immunol Immunother
. 2014 Oct;
64(2):213-24.
PMID: 25341809
In multiple myeloma (MM), bone marrow mesenchymal stromal cells (BM-MSCs) play an important role in pathogenesis and disease progression by supporting myeloma cell growth and immune escape. Previous studies have...
9.
Busser H, De Bruyn C, Urbain F, Najar M, Pieters K, Raicevic G, et al.
Stem Cells Dev
. 2014 May;
23(19):2390-400.
PMID: 24805167
Stem cell therapy is a potential method for the treatment of numerous diseases. The most frequent cellular source is bone-marrow-derived mesenchymal stromal cells (BM-MSCs). Human adipose-derived stromal cells (ADSCs) share...
10.
Philippart P, Meuleman N, Stamatopoulos B, Najar M, Pieters K, De Bruyn C, et al.
Tissue Eng Part A
. 2013 Aug;
20(1-2):160-70.
PMID: 23924315
Autologous mesenchymal stromal cell (MSC)-based therapies offer one of the most promising and safe methods for regeneration or reconstruction of tissues and organs. Routine procedures to obtain adequate amount of...